SEC Form 4/A · accession 0000899243-17-028595
G1 Therapeutics, Inc. · GTHX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
MedImmune Ventures, Inc.
10% Owner
Period of report
May 17, 2017
Accepted (ET)
Dec 13, 2017 · 11:46 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001560241
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value per shareF1 | May 17, 2017 | P | 75,000 | $15.00 | A | 3,409,536 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This Form 4 is being amended to reflect the correct transaction date for the purchase of 75,000 shares of common stock of G1 Therapeutics, Inc. on May 17, 2017.